257.64

0.04% 0.095

Cardinal Health Inc (CAH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$257.55

Offen:

$256.36

24-Stunden-Volumen:

674.13K

Relative Volume:

0.39

Marktkapitalisierung:

$59.66B

Einnahmen:

$250.74B

Nettoeinkommen (Verlust:

$1.55B

KGV:

39.40

EPS:

6.5398

Netto-Cashflow:

$4.39B

1W Leistung:

+4.00%

1M Leistung:

+14.13%

6M Leistung:

+25.73%

1J Leistung:

+62.37%

1-Tages-Spanne:

$254.74

$259.09

1-Wochen-Bereich:

$249.27

$257.55

52-Wochen-Spanne:

$155.84

$259.09

Cardinal Health Inc Stock (CAH) Company Profile

Firmenname

Cardinal Health Inc

Sektor

Healthcare (1052)

Branche

Medical Distribution (11)

Telefon

(614) 757-3033

Adresse

7000 CARDINAL PLACE, DUBLIN, OH

Mitarbeiter

63,900

Twitter

@cardinalhealth

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

CAH's Discussions on Twitter

Compare CAH vs MCK, COR, HSIC, AHG

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CAH Cardinal Health Inc	257.64	59.66B	250.74B	1.55B	4.39B	6.5398
MCK Mckesson Corp	1,016.21	118.48B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	340.32	64.94B	328.68B	2.55B	1.56B	13.03
HSIC Henry Schein Inc	85.31	9.51B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	1.211	1.04B	14.85M	-136.07M	7.25M	-0.4726

Cardinal Health Inc Stock (CAH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-08-19	Eingeleitet	RBC Capital Mkts	Outperform
2026-04-28	Eingeleitet	William Blair	Outperform
2026-01-09	Hochstufung	Citigroup	Neutral → Buy
2025-12-09	Eingeleitet	Barclays	Overweight
2025-06-03	Hochstufung	Wells Fargo	Equal Weight → Overweight
2025-02-05	Hochstufung	Jefferies	Hold → Buy
2025-01-08	Hochstufung	TD Cowen	Hold → Buy
2025-01-07	Hochstufung	Evercore ISI	In-line → Outperform
2025-01-06	Hochstufung	BofA Securities	Neutral → Buy
2024-12-13	Hochstufung	Wells Fargo	Underweight → Equal Weight
2024-12-04	Fortgesetzt	Mizuho	Outperform
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-02-09	Hochstufung	Argus	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Underweight
2023-07-10	Herabstufung	Evercore ISI	Outperform → In-line
2023-03-31	Eingeleitet	Citigroup	Neutral
2023-02-03	Hochstufung	Robert W. Baird	Neutral → Outperform
2022-11-04	Hochstufung	BofA Securities	Underperform → Neutral
2022-08-22	Fortgesetzt	Morgan Stanley	Overweight
2022-05-26	Herabstufung	Barclays	Overweight → Equal Weight
2022-05-18	Hochstufung	Evercore ISI	In-line → Outperform
2022-04-12	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-04-01	Fortgesetzt	Credit Suisse	Neutral
2021-08-06	Herabstufung	Deutsche Bank	Buy → Hold
2021-08-05	Herabstufung	BofA Securities	Buy → Underperform
2021-05-10	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-01-08	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-11-02	Hochstufung	Barclays	Equal Weight → Overweight
2020-09-25	Hochstufung	Deutsche Bank	Hold → Buy
2020-07-20	Hochstufung	Guggenheim	Neutral → Buy
2020-05-15	Hochstufung	UBS	Neutral → Buy
2020-04-23	Fortgesetzt	Credit Suisse	Neutral
2020-03-20	Hochstufung	BofA/Merrill	Underperform → Buy
2020-02-12	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-12-16	Herabstufung	Guggenheim	Buy → Neutral
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-08-27	Herabstufung	Argus	Buy → Hold
2019-08-20	Hochstufung	Guggenheim	Neutral → Buy
2019-04-18	Eingeleitet	Guggenheim	Neutral
2019-01-17	Eingeleitet	UBS	Neutral
2018-11-16	Herabstufung	Leerink Partners	Outperform → Mkt Perform
2018-04-24	Hochstufung	Leerink Partners	Mkt Perform → Outperform
2018-04-02	Hochstufung	Argus	Hold → Buy
2018-03-08	Eingeleitet	Barclays	Equal Weight
2018-02-27	Fortgesetzt	BofA/Merrill	Underperform
2018-01-05	Eingeleitet	Evercore ISI	In-line

Alle ansehen

Cardinal Health Inc Aktie (CAH) Neueste Nachrichten

Oct 20, 2026

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 20, 2026

Cardinal Health (CAH) Laps the Stock Market: Here's Why - Zacks Investment Research

Oct 20, 2026

Cardinal Health stock: UBS raises target from USD 280.00 to USD 295.00 - ad-hoc-news.de

Oct 20, 2026

Cardinal Health certified as a Great Place to Work across six regions - Chain Drug Review

Oct 20, 2026

Wall Street Zen downgrades Cardinal Health stock from Strong Buy to Buy - ad-hoc-news.de

Oct 20, 2026

Cardinal Health stock at EUR 224.80 pre-market: healthcare distributor - ad-hoc-news.de

Oct 20, 2026

Oct 18, 2026